Given the anticipated burden on healthcare systems due to growing and aging populations, and the need to expand universal health coverage across emerging markets, payers are increasingly debating economic instruments to control the market and limit budget impact. One area of debate is the application of price regulation to medical devices. The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
We have focused on two medical devices as case studies – coronary stents and implantable orthopaedic devices. Drawing on the local literature, data and interviews with local policymakers, experts and industry, the study sets out evidence on the impact of price regulation on the relationship between price and value, access to a wider number of medical devices, the intensity of competition today and the incentive to innovate in the future.